Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000376217> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2000376217 endingPage "192" @default.
- W2000376217 startingPage "179" @default.
- W2000376217 abstract "An evaluation was made of the protective effects of ICRF-186 [(L)1,2-bis(3,5-dioxopiperazinyl-l-yl)propane], the L-enantiomer of ICRF-187 [(D)1,2-bis(3,5-dioxopiperazinyl-l-yl)propane], against the cardiotoxicity and nephrotoxicity induced in spontaneously hypertensive rats (SHR) by doxorubicin. SHR were given doxorubicin (1 mg/kg, i.v.), once a week for 12 weeks. Group 1 (n = 10) received doxorubicin alone; Groups 2, 3 and 4 (each, n = 5) received ICRF-186, 25 mg/kg (group 2), 12.5 mg/kg (group 3) or 6.25 mg/kg (group 4), i.p., 30 min before each dose of doxorubicin. Two groups of control animals (each, n = 5) received 12 weekly i.p. injections of saline or 25 mg/kg ICRF-186. ICRF-186 provided significant protection, in a dose-dependent manner, against the cardiotoxicity and nephrotoxicity of doxorubicin and attenuated the increases in cardiac immune effector cells (interstitial dendritic cells, cytotoxic T-helper lymphocytes and macrophages) associated with this cardiotoxicity. The results of the study were compared with those obtained with ICRF-187 under identical experimental conditions. Analysis of the cardiomyopathy scores, nephropathy scores and counts of the numbers of immune effector cells in the heart showed that, at a dose of 25 mg/kg, ICRF-186 is a somewhat less effective protectant than ICRF-187. At a dose of 12.5 mg/kg, both compounds induced generally similar degrees of protection. At a dose of 6.25 mg/kg, both had comparable, but only minimal, protective effects." @default.
- W2000376217 created "2016-06-24" @default.
- W2000376217 creator A5024335893 @default.
- W2000376217 creator A5044739221 @default.
- W2000376217 creator A5083528812 @default.
- W2000376217 date "1994-09-01" @default.
- W2000376217 modified "2023-09-25" @default.
- W2000376217 title "Effects of ICRF-186 [(l)1,2-bis(3,5-dioxopiperazinyl-1-yl)propane] on the toxicity of doxorubicin in spontaneously hypertensive rats" @default.
- W2000376217 cites W1969275339 @default.
- W2000376217 cites W1970873535 @default.
- W2000376217 cites W2013051017 @default.
- W2000376217 cites W2035835567 @default.
- W2000376217 cites W2046781180 @default.
- W2000376217 cites W2056273512 @default.
- W2000376217 cites W2073397405 @default.
- W2000376217 cites W2074572545 @default.
- W2000376217 cites W2079577433 @default.
- W2000376217 cites W2178975869 @default.
- W2000376217 cites W2325508287 @default.
- W2000376217 cites W4247128285 @default.
- W2000376217 doi "https://doi.org/10.1016/0300-483x(94)90176-7" @default.
- W2000376217 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7940559" @default.
- W2000376217 hasPublicationYear "1994" @default.
- W2000376217 type Work @default.
- W2000376217 sameAs 2000376217 @default.
- W2000376217 citedByCount "16" @default.
- W2000376217 countsByYear W20003762172013 @default.
- W2000376217 countsByYear W20003762172018 @default.
- W2000376217 countsByYear W20003762172019 @default.
- W2000376217 countsByYear W20003762172020 @default.
- W2000376217 countsByYear W20003762172021 @default.
- W2000376217 countsByYear W20003762172022 @default.
- W2000376217 crossrefType "journal-article" @default.
- W2000376217 hasAuthorship W2000376217A5024335893 @default.
- W2000376217 hasAuthorship W2000376217A5044739221 @default.
- W2000376217 hasAuthorship W2000376217A5083528812 @default.
- W2000376217 hasConcept C126189478 @default.
- W2000376217 hasConcept C126322002 @default.
- W2000376217 hasConcept C134018914 @default.
- W2000376217 hasConcept C185592680 @default.
- W2000376217 hasConcept C2776694085 @default.
- W2000376217 hasConcept C2778233292 @default.
- W2000376217 hasConcept C2781303535 @default.
- W2000376217 hasConcept C29730261 @default.
- W2000376217 hasConcept C71924100 @default.
- W2000376217 hasConcept C98274493 @default.
- W2000376217 hasConceptScore W2000376217C126189478 @default.
- W2000376217 hasConceptScore W2000376217C126322002 @default.
- W2000376217 hasConceptScore W2000376217C134018914 @default.
- W2000376217 hasConceptScore W2000376217C185592680 @default.
- W2000376217 hasConceptScore W2000376217C2776694085 @default.
- W2000376217 hasConceptScore W2000376217C2778233292 @default.
- W2000376217 hasConceptScore W2000376217C2781303535 @default.
- W2000376217 hasConceptScore W2000376217C29730261 @default.
- W2000376217 hasConceptScore W2000376217C71924100 @default.
- W2000376217 hasConceptScore W2000376217C98274493 @default.
- W2000376217 hasIssue "1-3" @default.
- W2000376217 hasLocation W20003762171 @default.
- W2000376217 hasLocation W20003762172 @default.
- W2000376217 hasOpenAccess W2000376217 @default.
- W2000376217 hasPrimaryLocation W20003762171 @default.
- W2000376217 hasRelatedWork W2033536583 @default.
- W2000376217 hasRelatedWork W2051742647 @default.
- W2000376217 hasRelatedWork W2093442802 @default.
- W2000376217 hasRelatedWork W2114825337 @default.
- W2000376217 hasRelatedWork W2980829266 @default.
- W2000376217 hasRelatedWork W3018019957 @default.
- W2000376217 hasRelatedWork W3093215486 @default.
- W2000376217 hasRelatedWork W3209127409 @default.
- W2000376217 hasRelatedWork W4296261120 @default.
- W2000376217 hasRelatedWork W89677992 @default.
- W2000376217 hasVolume "92" @default.
- W2000376217 isParatext "false" @default.
- W2000376217 isRetracted "false" @default.
- W2000376217 magId "2000376217" @default.
- W2000376217 workType "article" @default.